top of page

Weight Loss

GLP-1 Medications: A Breakthrough in Weight and Diabetes Management

GLP-1 receptor agonists—such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) and Liraglutide—represent a significant advancement in the treatment of type 2 diabetes and obesity.

Originally developed to help manage blood sugar, these medications have also been shown to be highly effective for sustainable weight loss. When combined with personalized lifestyle changes—like healthy eating and regular physical activity—patients can experience meaningful improvements in both weight and metabolic health.

✅ Benefits:

  • Supports healthy weight loss

  • Improves blood sugar control

  • Reduces hunger and improves satiety

  • May improve heart health markers

⚕️ Safe Use Under Medical Guidance

GLP-1 medications are generally well tolerated. Most side effects are mild, such as nausea or digestive upset, and can often be managed by adjusting the dose or timing.

Screenshot 2025-07-27 at 7.57_edited.jpg

Concierge Weight Loss with GLP‑1 Therapies

  • Personalized.
  • Private. Clinician‑guided.
  • Achieve sustainable weight loss with a modern, concierge approach that combines lifestyle coaching and advanced GLP‑1–based therapies—delivered with discretion and individualized care.

A Smarter Way to Lose Weight

Our practice offers comprehensive metabolic care designed around you. We start with a thorough intake, labs when appropriate, and ongoing check‑ins to help you reach real, lasting results.

What you can expect:

  • One‑on‑one concierge support

  • Individualized treatment plans

  • Ongoing monitoring and adjustments

  • Secure, private communication

Who This Is For?

  • Adults seeking medically guided weight loss

  • Individuals who value privacy and personalized care

  • Patients looking for an alternative to one‑size‑fits‑all programs

A medical screening is required. Not all patients are candidates for GLP‑1 therapies.

Safety & Transparency

  • Care is provided by licensed clinicians

  • Potential benefits, risks, and alternatives are reviewed before starting

  • Ongoing monitoring for effectiveness and side effects

 
Important notes:
  • Compounded medications are prepared by accredited pharmacies when commercially available options are not suitable.

  • Sublingual tirzepatide is prescribed off‑label; individual results may vary.

  • This service is not a substitute for emergency care.

GLP‑1 Therapies, Personalized

GLP‑1 receptor agonists can help reduce appetite, improve satiety, and support healthier metabolic signaling when paired with nutrition and movement strategies.

Tirzepatide (Sublingual Option)

We now offer tirzepatide in carefully compounded, sublingual doses for select patients as part of a clinician‑directed plan.

Why patients choose this option:
  • Customized dosing based on tolerance and goals

  • Discreet administration

  • Close medical supervision

Treatment options and dosing are determined after a medical evaluation to ensure safety and appropriateness.

Our Concierge Difference:
  • Access: Direct communication with your clinician

  • Customization: Doses and plans tailored to your response

  • Continuity: Regular follow‑ups and progress tracking

  • Support: Nutrition, movement, and habit coaching integrated

Get Started!

  • Take the first step toward a healthier weight with care that fits your life.

  • Schedule a private consultation to see if our concierge GLP‑1 program is right for you.

Our Services-Our Services-2.jpg
Screenshot 2025-07-27 at 7.58_edited.jpg

⚠️ Disclaimer:  
Not all weight loss medications listed are appropriate or prescribed for every individual.  Price of medications not included in memberships. This information is provided solely for educational and informational purposes. All therapies must be personalized and discussed with a qualified healthcare provider to assess safety, suitability, and potential benefits. Some compounds may be considered off-label or research-based and may not have FDA approval for specific indications. Additionally, intramuscular (I.M.) and Subcutaneous  medications may be limited or restricted in certain jurisdictions due to local regulations or scope-of-practice laws.

Website Disclaimer: 

The information on this website is for general information purposes only. Nothing on this site should be taken as healthcare advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, a healthcare professional-patient relationship. We do our best to keep information accurate and up to date, however mistakes do happen, and we cannot make guarantees regarding the accuracy of our information. We are not liable for any information on this website or your reliance upon it.

 

 

 

Use of this website to submit information may not be completely secure or HIPAA compliant.  The use of the Internet or this form for communication with our Company or any individual member of our Company does not establish a professional relationship. Confidential or time-sensitive material should not be submitted using this form and there is not a guarantee of a response time or a response at all, although we do our best to respond to each inquiry. Submitting this form confirms my understanding.

  • Facebook
  • Instagram
  • X
  • TikTok

2082 Michelson Drive, Suite 100

Irvine California, 92612

We are currently accepting telehealth patients in CA & NV.

 

© 2025 by Sesi Signature Inc.

bottom of page